Intensification of remission induction therapy for acute nonlymphocytic leukemia (ANLL). I. Response and toxicity in four different regimens

Blut. 1979 Aug;39(2):133-40. doi: 10.1007/BF01008088.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Age Factors
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Ifosfamide / therapeutic use
  • Leukemia / drug therapy*
  • Methods
  • Middle Aged
  • Thioguanine / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Cytarabine
  • Vincristine
  • Thioguanine
  • Ifosfamide
  • Daunorubicin